Dec 7, 2022 4:05pm EST Inhibikase Therapeutics Provides Update to FDA Clinical Hold of IkT-148009 Programs
Nov 22, 2022 8:00am EST Inhibikase Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference